1st Quarter - Termination — VIAL HEALTH TECHNOLOGY, INC. for VIAL HEALTH TECHNOLOGY, INC. (2026)

Firm

VIAL HEALTH TECHNOLOGY, INC.

Client

VIAL HEALTH TECHNOLOGY, INC.

Income

—

Expenses

—

Terminated

Mar 2, 2026

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and policy issues related to drug development and clinical trials

Lobbyist	Covered position, as disclosed
PAOLO MASTRANGELO	—

Contacted: Defense, Dept of (DOD); White House Office; SENATE; Natl Institutes of Health (NIH); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Vice President of the U.S.

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.